Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Map
Live
Schedule
Daily Record
Special Rules
Subpoenas
House Ethics
Foreign Influence
Agencies
Regulations
Office Spending
US Code
Open search

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
6,540
Regulations.gov

Showing 30 of 6,540 dockets

Nonrulemaking
NRC

NRC-2025-0091

Southern Nuclear Operating Company; Edwin I. Hatch Nuclear Plant, Units 1 and 2; Subsequent License Renewal Application

3 docsNo comments
Rulemaking
EPA
Open for Comments

EPA-R09-OAR-2026-1257

Error Correction and Finding of Failure to Attain the 2006 24-Hour PM2.5 Standards; California; San Joaquin Valley

6 docsNo comments
Comments due May 5, 2026
Nonrulemaking
FDA

FDA-2024-H-2420

DAB Civil Money Penalty; JM Jog LLC d/b/a Sunoco / Pump and Munch

2 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-3155

DAB Civil Money Penalty; Heart of the Bay Gift Shop & Smoke Shop d/b/a Heart of the Bay Smoke Shop

1 docNo comments
Rulemaking
SSA

SSA-2025-0420

Incorrect Terminology in Regulatory Text; Technical Amendments Final Rule

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-2163

DAB Civil Money Penalty; Two Brother Main LLC, d/b/a Cigar N Vape; CLOSED 04/02/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-1886

DAB Civil Money Penalty; Deyanira Izaguirre Martinez d/b/a Martinez Mini Mart & Taqueria; CLOSED 04/02/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2026-H-1775

DAB Civil Money Penalty; Sandra Gonzalez d/b/a G’z Mini Mart; CLOSED 04/02/2026

1 docNo comments
Nonrulemaking
DOT
Open for Comments

DOT-OST-2026-1057

60-Day Notice of Request for Renewal of a Previously Approved Collection

1 docNo comments
Comments due Jun 2, 2026
Nonrulemaking
FRA
Open for Comments

FRA-2020-0030

American Short Line and Regional Railroad Association

9 docs1 comment
Comments due Apr 2, 2026
Nonrulemaking
EBSA
Open for Comments

EBSA-2026-0199

Proposed Exemption for The Goldman Sachs Group, Inc. (Goldman) Located in New York, New York (Case No. 12122)

1 docNo comments
Comments due May 15, 2026
Nonrulemaking
PHMSA
Open for Comments

PHMSA-2016-0004

Tennessee Gas Pipeline, L.L.C - Special Permit (OPID 19160)

34 docs11 comments
Comments due Oct 28, 2025
Nonrulemaking
PHMSA
Open for Comments

PHMSA-2016-0008

Colorado Interstate Gas Company, L.L.C. (OPID 2564) - Special Permit

21 docs2 comments
Comments due Jun 28, 2022
Nonrulemaking
DOT
Open for Comments

DOT-OST-2016-0200

National Air Cargo Group, Inc. d/b/a National Airlines - Application for Exemption

12 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-2118

Airborne Custom Spraying, Inc. - Exemption/Rulemaking

2 docs1 comment
Comments due Apr 2, 2026
Nonrulemaking
FAA
Open for Comments

FAA-2026-2096

Horizon Air - Exemption/Rulemaking

3 docs1 comment
Nonrulemaking
FAA
Open for Comments

FAA-2024-2354

Buchheit Drone Service, LLC - Exemption/Rulemaking

6 docsNo comments
Nonrulemaking
FAA
Open for Comments

FAA-2026-3010

Austin Corman - Exemption/Rulemaking

3 docsNo comments
Nonrulemaking
FDA

FDA-2025-P-0253

Request that the FDA make a determination if the RLD, Inapsine Injection, 2.5mg/mL (N016796) was withdrawn for safety or effectiveness reasons

5 docsNo comments
Nonrulemaking
FDA

FDA-2016-V-3709

Laser Light Show

7 docsNo comments
Rulemaking
EPA

EPA-HQ-OPPT-2021-0202

Regulation of Persistent, Bioaccumulative, and Toxic Chemicals Under TSCA Section 6(h)

47 docs126 comments
Nonrulemaking
FDA

FDA-2025-P-5430

Requests that the FDA determine whether the Reference Listed Drug (RLD), INAPSINE® (droperidol) Injection, 2.5 mg/mL approved under New Drug Application (NDA) Number N016796, held by Rising Pharma Holdings Inc has not been withdrawn from sale for safety or effectiveness reasons.

6 docsNo comments
Nonrulemaking
FDA

FDA-2026-V-1453

Laser Light Show

3 docsNo comments
Nonrulemaking
USN
Open for Comments

USN-2026-HQ-0166

Challenges of Operational Environments Study; OMB Control Number 0703-0100

3 docsNo comments
Comments due May 27, 2026
Nonrulemaking
FDA

FDA-2026-V-1588

Laser Light Show

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-V-1689

Laser Light Show

3 docsNo comments
Nonrulemaking
DOT
Open for Comments

DOT-OST-2012-0058

IATA Traffic Conference Actions Tentatively Exempted From Filing for Approval

136 docs1 comment
Nonrulemaking
FDA

FDA-2026-V-1974

Laser Light Show

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-V-1762

Laser Light Show

3 docsNo comments
Nonrulemaking
FDA

FDA-2026-V-1687

Laser Light Show

3 docsNo comments
  • Previous
  • Page 111 of 218
  • Next